Re: Back to the FDA
in response to
by
posted on
Oct 03, 2019 09:16PM
,,,,accchhhh,,relax,,,,,,its going to go down like this!!,,,DM will move that the crestor/208 patent will be sold to an obscure pharma for $500 miilion,,,plus royalty stream,,,,thats a ruff estimate of course,,,then after all the data is out and in the open,,,,,,,,cognitive impairment data will be so compelling RVX will sell the rights to it to Bayer Corp. for ruffly $200 million give or take and of course a royalty stream,,,,,,,,,,,on the heels of these sales will come a news release noting that 208 will be put into trial around CKD asap.,,in tandem with this activity our pipeline of other molecules will start to be pushed into early phase trials,,,,,,,,,,,,,,,,,,,,,,,,and on and on,,,,,,,,,,yep,,,,received my crystal ball off amazon this afternoon,,,,send a pm and Ill return the link,,,,!!!